A New Alzheimer’s Blood Test Approved in the U.S.—But Canada Must Catch Up
The U.S. Food and Drug Administration (FDA) approved a groundbreaking new blood test designed to assist in the diagnosis of Alzheimer’s disease.
Developed by Roche, the Elecsys pTau181 test measures levels of a specific molecule—a phosphorylated form of the tau protein—in the blood.
